Revenue Dynamics YoY (Last Twelve Months): ImmuCell Corporation Inc (ICCC)

Graphic logo of immucell.com (ICCC)

ImmuCell Corporation (ICCC) possesses unquestionable authority in calf immunity protection, which confirms the status of the FirstDefense brand. This chart from the GURU.Markets platform illustrates the annual growth in sales volume for the TTM, where the value of 19.20 reflects this status. The company's success is based on the trust of American farms in veterinary products, while revenues rely on livestock demand and the quality of vaccine distribution.

ImmuCell Corp. (ICCC) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/18/2026

immucell.com - analytical breakdowns and key metrics (ICCC)

- company stock exchange capitalization indicators:
Analysis of all company metrics:ImmuCell Corp.
Manufactured product of ImmuCell Corporation

Stable supplies of veterinary drugs from ImmuCell Corporation (ICCC) generate a steady cash flow for operational activities. This indicator measures the percentage change in revenue over a rolling twelve-month period, capturing the pace of business expansion on a daily basis. The metric allows for a real-time assessment of demand dynamics by eliminating seasonal reporting distortions. However, rapid growth may mask liquidity risks during a cycle shift. Analyze the year-over-year sales trend over the last 12 months to evaluate capital stability.